Details for 2021152314
Up to date per 20.04.2026
Actions
Details for 2021152314
Granted/Registered
European Patent
29.09.2021 A
15.11.2023 B1
03.12.2010
US
41939510 P
A61K 31/485 20060101AFI20210823BHEP
Owner
Nalpropion Pharmaceuticals LLC155 Franklin Rd, Suite 450 Brentwood, TN 37027US
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
FLANAGAN,, Shawn14083 Via Corsini San Diego,, CA California 92128US
DUNAYEVICH,, Eduardo1030 Deep Wood Drive Westlake Village,, CA California 91362US
Information about Fees